Related references
Note: Only part of the references are listed.GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 (vol 17, pg 954, 2018)
Ali H. Mokdad
LANCET NEUROLOGY (2021)
Psychometric Validation of the Role Function Restrictive Domain of the Migraine Specific Quality-of-Life Questionnaire Version 2.1 Electronic Patient-Reported Outcome in Patients With Episodic and Chronic Migraine
Rebecca M. Speck et al.
HEADACHE (2019)
Two randomized migraine studies of galcanezumab Effects on patient functioning and disability
Janet H. Ford et al.
NEUROLOGY (2019)
Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
Vladimir Skljarevski et al.
CEPHALALGIA (2018)
Evaluation of Galcanezumab for the Prevention of Episodic Migraine The EVOLVE-1 Randomized Clinical Trial
Virginia L. Stauffer et al.
JAMA NEUROLOGY (2018)
Galcanezumab in chronic migraine The randomized, double-blind, placebo-controlled REGAIN study
Holland C. Detke et al.
NEUROLOGY (2018)
Global, regional, and national burden of meningitis, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Joseph Raymond Zunt et al.
LANCET NEUROLOGY (2018)
Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Lars Jacob Stovner et al.
LANCET NEUROLOGY (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
Quality of life in primary headache disorders: A review
Norazah Abu Bakar et al.
CEPHALALGIA (2016)
The International Classification of Headache Disorders, 3rd edition (beta version)
Andre Bes et al.
CEPHALALGIA (2013)
The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients
Regina Rendas-Baum et al.
QUALITY OF LIFE RESEARCH (2013)
Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs
Daniel Lakens
FRONTIERS IN PSYCHOLOGY (2013)
Validating Migraine-Specific Quality of Life Questionnaire v2.1 in Episodic and Chronic Migraine
Christine L. Bagley et al.
HEADACHE (2012)
Assessing and Managing All Aspects of Migraine: Migraine Attacks, Migraine-Related Functional Impairment, Common Comorbidities, and Quality of Life
Dawn C. Buse et al.
MAYO CLINIC PROCEEDINGS (2009)
Healthcare provider-patient communication and migraine assessment: results of the American Migraine Communication Study, phase II
Steven R. Hahn et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
In-office discussions of migraine: Results from the American migraine communication study
Richard B. Lipton et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2008)
Defining clinically meaningful change in health-related quality of life
RD Crosby et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2003)
Information about migraine disability influences physicians' perceptions of illness severity and treatment needs
WF Holmes et al.
HEADACHE (2001)
Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability
WF Stewart et al.
NEUROLOGY (2001)
Validity and reliability of the Migraine-Specific Quality of Life Questionnaire (MSQ version 2.1)
BC Martin et al.
HEADACHE (2000)
Share Paper
